DOSIsoft Launches DOSIsoft Theranostics for Personalized Nuclear Medicine

DOSIsoft has launched DOSIsoft Theranostics, a dedicated organization focused on advancing software for personalized nuclear medicine and theranostics, announced in a press release. The new entity aims to accelerate innovation and expand clinical adoption of radiopharmaceutical therapy solutions.

DOSIsoft Theranostics will operate independently, developing tools that integrate diagnostics and targeted therapies to support routine clinical workflows. The organization will focus on software for individualized therapy monitoring across different imaging modalities and treatment cycles.

At the center of the new entity’s portfolio is PLANET, DOSIsoft’s FDA cleared and CE marked platform that supports multi radionuclide dosimetry and multimodality DICOM interoperability. PLANET is already used in hospitals and research centers worldwide with a vendor neutral design that accommodates diverse clinical workflows.

DOSIsoft Theranostics will present its solutions at SNMMI 2026 and continue to collaborate with hospitals and research institutions to support quantitative imaging and personalized care in nuclear medicine.